Fwd: G+: Improving Public Health through Vaccines

This week's FierceVaccines is brought to you by Gerson Lehrman Group, Inc.

Dear Colleague, Priorities for vaccine development are the subject of intense debate: should funding go to research, infrastr ucture or delivery? Find out what global vaccine experts from industry, academia and healthcare think in this survey presented by G+, part of Gerson Lehrman Group, Inc. You will get perspectives from thought leaders on the most pressing issues, interesting approaches and critical perspectives on vaccine development. With this survey, you gain a better understanding of the challenges in improving public health through immunization science and policy. Best Regards, The G+ Team Where people, ideas and new opportunities meet About G+ G+ is a community where th e world's most active and influential professionals, academics and entrepreneurs connect. G+ provides a place for people to start new conversations, ask the important questions and propose ideas online and at in-person meetings. Join the conversation online at GPlus.com.

 

Want to reach 18,000+ FierceVaccines subscribers with your own message? Contact ryan@fiercemarkets.com or call 202-824-5089.   About this email: In order to receive FierceVaccines for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceVaccines. Click here to unsubscribe. FierceMarkets 1900 L St. NW Suite 400  Washington, DC 20036

Custom Search